Streetinsider.com’s Hot Lunchtime Reads 7/2: (VRTX) (TWTR) (AMD) (MDCO) (AMBA) by Street InsiderJuly 2, 2015April 15, 2020095 The following is a list of notable articles to help get you through the lunch hour: Vertex Pharma (VRTX) ORKAMBI Approved by FDA -> Read this! AMD (AMD) Shares Strengthens Amid Activity in Weekly Calls -> Read this! Facebook’s (FB) Zuckerberg Interested in Twitter (TWTR) – re/code -> Read this! Medicines (MDCO) Loss of Exclusivity on Angiomax Seen as ‘Anticipated Event’ – RBC -> Read this! Vislab Adds Computer Vision to Ambarella’s (AMBA) Portfolio; Chardan Affirms at ‘Neutral’ -> Read this!
